These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 409573)

  • 1. The effect of glycosaminoglycans on the in vitro activity of human skin fibroblast glycosphingolipid beta-galactosidases and neuraminidases.
    Rushton AR; Dawson G
    Clin Chim Acta; 1977 Oct; 80(1):133-9. PubMed ID: 409573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro restoration of deficient beta-galactosidase activity in liver of patients with Hurler and Hunter disease.
    Kint JA
    Nature; 1974 Aug; 250(465):424-5. PubMed ID: 4212078
    [No Abstract]   [Full Text] [Related]  

  • 3. Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients. Inhibition of the activity in vitro by sulfated glycosaminoglycans and other compounds.
    Baumkötter J; Cantz M
    Biochim Biophys Acta; 1983 Dec; 761(2):163-70. PubMed ID: 6418214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of galactosylceramidase activation by phosphatidylserine.
    Hanada E; Suzuki K
    Biochim Biophys Acta; 1980 Aug; 619(2):396-402. PubMed ID: 6773584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of human hepatic beta-galactosidase toward natural glycosphingolipid substrates.
    Tanaka H; Meisler M; Suzuki K
    Biochim Biophys Acta; 1975 Sep; 398(3):452-63. PubMed ID: 1174525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of GM1-gangliosidosis type I: glycosphingolipid profiles of urine and transformed lymphocytes and beta-D-galactosidase activities in peripheral lymphocytes, cultured skin fibroblasts and transformed lymphocytes.
    Asano K; Shindo N; Nakasuji M; Inamori K; Ohta M; Matsushita T; Yamaguchi M; Oshima M
    Jpn J Exp Med; 1990 Apr; 60(2):73-9. PubMed ID: 2117086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mucolipidosis. biologic characteristics (author's transl)].
    Gatti R; Borrone C; Torreblanca J; Cavalieri S; de Martini I; Filocamo M; Antelo MC
    An Esp Pediatr; 1979; 12(8-9):563-74. PubMed ID: 115347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosphinoglipid beta-galactosidases of cultured mammalian cells. Characterization of the enzymes from mouse cell line lmtk and human Lesch-Nyhan fibroblasts.
    Rushton AR; Dawson G
    Biochim Biophys Acta; 1975 Apr; 388(1):92-105. PubMed ID: 236034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of (+) --cyanidanol on lysosomal enzymes of I-cell fibroblasts.
    Tavella D; Donnelly PV; Di Ferrante N
    Tex Rep Biol Med; 1976; 34(2-4):307-14. PubMed ID: 20673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-galactosidases in fibroblasts: Hurler and Sanfilippo syndromes.
    Benson PF; Bowser-Riley F; Giannelli F
    N Engl J Med; 1970 Oct; 283(18):999-1000. PubMed ID: 4248669
    [No Abstract]   [Full Text] [Related]  

  • 12. Inherited lysosomal storage disease associated with deficiencies of beta-galactosidase and alpha-neuraminidase in sheep.
    Ahern-Rindell AJ; Prieur DJ; Murnane RD; Raghavan SS; Daniel PF; McCluer RH; Walkley SU; Parish SM
    Am J Med Genet; 1988 Sep; 31(1):39-56. PubMed ID: 3146925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
    Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
    Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the properties and bile salt specificities of galactosylceramide and lactosyl ceramide beta-galactosidase activities in human leucocytes and fibroblasts.
    Poulos A; Beckman K
    Clin Chim Acta; 1980 Feb; 101(2-3):277-85. PubMed ID: 6766828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microassay for acid beta-galactosidase activity toward asialofetuin.
    Mutoh T; Naoi M; Sobue I; Kiuchi K; Nagatsu T
    Clin Chim Acta; 1985 Nov; 152(3):307-14. PubMed ID: 2415273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced glycosaminoglycan storage: dose-dependent changes in the pattern of accumulated glycosaminoglycans in cultured bovine and human fibroblasts.
    Fischer J
    Biochem Pharmacol; 1996 Nov; 52(9):1331-7. PubMed ID: 8937442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency.
    Van Diggelen OP; Schram AW; Sinnott ML; Smith PJ; Robinson D; Galjaard H
    Biochem J; 1981 Oct; 200(1):143-51. PubMed ID: 6800355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucopolysaccharidoses and mucolipidoses.
    Van Hoof F
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():64-93. PubMed ID: 4220223
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment related observations in solid tissues, fibroblast cultured and amniotic fluid cells of type II glycogenosis, Hurler disease and metachromatic leukodystrophy.
    Hug G; Schubert WK; Soukup S
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):160-83. PubMed ID: 4215475
    [No Abstract]   [Full Text] [Related]  

  • 20. Morquio B syndrome: a primary defect in beta-galactosidase.
    van der Horst GT; Kleijer WJ; Hoogeveen AT; Huijmans JG; Blom W; van Diggelen OP
    Am J Med Genet; 1983 Oct; 16(2):261-75. PubMed ID: 6418007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.